FDA grants fast track review to Glenveigh Digoxin Immune Fab
Glenveigh Medical founder and chairman Dr. David Adair said DIF is taking treatment to a level that hasn’t been available before for women with severe preeclampsia. "In particular,
WellSpan Health and Johns Hopkins Medicine have renewed their oncology collaboration, aiming to widen patient access to advanced care, clinical expertise, and research initiatives throughout central Pennsylvania, US.
The voice recognition technology was designed to confirm prescription medications before administration at home or in medical center, thereby preventing medication errors. SafeCode technology provides access to prescription